We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IT:NYSEGartner, Inc. Analysis

Data as of 2026-03-13 - not real-time

$166.51

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Gartner, Inc. (IT) trades at $166.51, marginally below its DCF fair value of $170.50, offering roughly a 14% upside potential. Valuation metrics such as a trailing P/E of 17.3 are well under the industry average of 33.7, suggesting the stock is undervalued. The company delivers exceptional profitability with a gross margin of 68.4%, operating margin of 19.0% and an ROE of 86.9%, far exceeding typical peers. However, the technical outlook remains bearish: the 20‑day SMA (159.27) sits below the current price, but the 200‑day SMA (264.66) is far higher, the trend direction is flagged as bearish, volume is decreasing, and the RSI at 47.3 indicates neutral momentum. The MACD histogram is positive, hinting at a potential short‑term bounce, yet the broader price action stays constrained between a support of $143.55 and resistance near $172.23. Volatility is elevated at 80.6% over the past 30 days, and beta hovers around 0.95‑1.08, implying market‑aligned risk. Recent news highlights Gartner’s projection that global AI spending will reach $2.52 trillion in 2026, a tailwind for its Insights and Consulting segments, while market commentary (e.g., Jim Cramer) flags competitive pressure from AI platforms. The firm carries no dividend, and its debt‑to‑equity ratio is high, though cash generation remains robust with free cash flow of $922.8 M. In summary, strong fundamentals and a modest valuation discount are offset by a bearish technical setting and heightened volatility.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish trend direction and decreasing volume
  • Price near technical resistance with limited upside
  • Neutral RSI and modest MACD bullish signal

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Valuation discount relative to industry P/E
  • Strong profitability and high ROE
  • AI spending growth supporting revenue outlook

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable earnings generation and cash flow
  • Strategic positioning in high‑growth AI and consulting markets
  • Undervalued price relative to DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth2.20%
Profit Margin11.22%
P/E Ratio17.3
ROE86.86%
ROA8.86%
Debt/Equity1046.54
P/B Ratio36.9
Op. Cash Flow$1.3B
Free Cash Flow$922.8M
Industry P/E33.7

Technical Analysis

TrendBearish
RSI47.3
Support$143.55
Resistance$172.23
MA 20$159.27
MA 50$191.62
MA 200$264.66
MACDBullish
VolumeDecreasing
Fear & Greed Index72.48

Valuation

Fair Value$170.50
Target Price$190.46
Upside/Downside14.38%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.95
Volatility80.56%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.